Literature DB >> 11788450

Injury in renal ischemia-reperfusion is independent from immunoglobulins and T lymphocytes.

Pierce Park1, Mark Haas, Patrick N Cunningham, Lihua Bao, Jessy J Alexander, Richard J Quigg.   

Abstract

Ischemia-reperfusion injury (IRI) is a complex and incompletely understood process involving a cascade of events that culminates in apoptotic and/or necrotic cell death. Natural IgM antibodies and complement have been implicated in the pathogenesis of IRI in a variety of organ systems as have T lymphocytes in renal IRI. To investigate the role of Ig and T lymphocytes in renal IRI, recombination-activating gene (RAG)-1-deficient mice were studied. RAG-1(-/-) mice were not protected from acute renal failure induced by 27.5 min of bilateral renal ischemia and subsequent reperfusion [serum urea nitrogen levels 30 h after reperfusion, 155.2 +/- 5.6 and 152.8 +/- 11.4 mg/dl in RAG-1(-/-) and wild-type mice, respectively; n = 13 each]. Histological examination showed acute tubular necrosis and neutrophilic infiltration with no significant differences between groups. In contrast with other organ systems, Igs were not found in kidneys at time points ranging from 1 min to 30 h after ischemia. Thus Igs and mature T lymphocytes do not appear to play a significant role in the pathogenesis of IRI in the kidney.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11788450     DOI: 10.1152/ajprenal.00160.2001

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  44 in total

Review 1.  Ischemia-reperfusion and immediate T cell responses.

Authors:  Yanfei Huang; Hamid Rabb; Karl L Womer
Journal:  Cell Immunol       Date:  2007-10-17       Impact factor: 4.868

2.  Chemokine receptor CCR1 regulates inflammatory cell infiltration after renal ischemia-reperfusion injury.

Authors:  Kengo Furuichi; Ji-Liang Gao; Richard Horuk; Takashi Wada; Shuichi Kaneko; Philip M Murphy
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

Review 3.  Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD.

Authors:  David A Ferenbach; Joseph V Bonventre
Journal:  Nat Rev Nephrol       Date:  2015-02-03       Impact factor: 28.314

4.  TLR4-mediated Cox-2 expression increases intestinal ischemia/reperfusion-induced damage.

Authors:  Tiffany Moses; Lynn Wagner; Sherry D Fleming
Journal:  J Leukoc Biol       Date:  2009-06-29       Impact factor: 4.962

5.  High renal ischemia temperature increases neutrophil chemoattractant production and tissue injury during reperfusion without an identifiable role for CD4 T cells in the injury.

Authors:  Nobuyuki Fukuzawa; Austin D Schenk; Marianne Petro; Katsuya Nonomura; William M Baldwin; Robert L Fairchild
Journal:  Transpl Immunol       Date:  2009-08-05       Impact factor: 1.708

Review 6.  Inflammation in acute kidney injury.

Authors:  Gilbert R Kinsey; Li Li; Mark D Okusa
Journal:  Nephron Exp Nephrol       Date:  2008-09-18

7.  Role of adhesion molecules and dendritic cells in rat hepatic/renal ischemia-reperfusion injury and anti-adhesive intervention with anti-P-selectin lectin-EGF domain monoclonal antibody.

Authors:  Tong Zhou; Gui-Zhi Sun; Ming-Jun Zhang; Jin-Lian Chen; Dong-Qing Zhang; Qing-Shen Hu; Yu-Ying Chen; Nan Chen
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

Review 8.  Renal repair: role of bone marrow stem cells.

Authors:  Fangming Lin
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

9.  Blocking properdin, the alternative pathway, and anaphylatoxin receptors ameliorates renal ischemia-reperfusion injury in decay-accelerating factor and CD59 double-knockout mice.

Authors:  Takashi Miwa; Sayaka Sato; Damodar Gullipalli; Masaomi Nangaku; Wen-Chao Song
Journal:  J Immunol       Date:  2013-02-20       Impact factor: 5.422

Review 10.  Leukocyte recruitment and acute renal failure.

Authors:  Kai Singbartl; Klaus Ley
Journal:  J Mol Med (Berl)       Date:  2003-12-10       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.